Top 10 Most Popular Infection Control Today Articles of 2022: 10, 9, 8
This last week of 2022, Infection Control Today® reviews the most popular articles. Here are the 10th, 9th, and 8th.
Infection Control Today® (ICT®) strives all year to give you the best, most helpful information to do your job. Starting with the 10th most popular article, we will countdown the Top 10 most popular articles ICT® posted in 2022.
Here are ICT®'s 10th, 9th, and 8th most popular articles from 2022:
10th Most Popular: COVID-19 Infecting White Tail Deer to Create Transmission Danger
COVID-19 seems to be present in many white-tail deer. The danger posed by that includes COVID-19 mutating into a new variant that reinfects humans, says a study.
9th Most Popular: Environmental Measures Disrupt Transmission of HAIs
Time, staff, and budget constraints make it difficult to expand HAI mitigation programs despite the obvious and urgent need to do so.
8th Most Popular: Best Handwashing Technique: WHO’s 6-Step Process Is Effective, but Data Inconclusive
The goal of the review was to examine the efficacy of the World Health Organization’s 6-step handwashing technique and compare its efficacy with other handwashing techniques.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
